{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:08:57Z","timestamp":1793362137055,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Perioper Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The impact of sugammadex in patients with end-stage renal disease undergoing kidney transplantation is still far from being defined. The aim of the study is to compare sugammadex to neostigmine for reversal of rocuronium- and cisatracurium-induced neuromuscular block (NMB), respectively, in patients undergoing kidney transplantation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A single-center, 2014-2017 retrospective cohort case-control study was performed. A total of 350 patients undergoing kidney transplantation, equally divided between a sugammadex group (175 patients) and a neostigmine group (175 patients), were considered. Postoperative kidney function, evaluated by monitoring of serum creatinine and urea and estimated glomerular filtration rate (eGFR), was the endpoint. Other endpoints were anesthetic and surgical times, post-anesthesia care unit length of stay, postoperative intensive care unit admission, and recurrent NMB or complications.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>No significant differences in patient or, with the exception of drugs involved in NMB management, anesthetic, and surgical characteristics, were observed between the two groups. Serum creatinine (median [interquartile range]: 596.0 [478.0-749.0] vs 639.0 [527.7-870.0] \u03bcmol\/L, <jats:italic>p<\/jats:italic> = 0.0128) and serum urea (14.9 [10.8-21.6] vs 17.1 [13.1-22.0] mmol\/L, <jats:italic>p<\/jats:italic> = 0.0486) were lower, while eGFR (8.0 [6.0-11.0] vs 8.0 [6.0-10.0], <jats:italic>p<\/jats:italic> = 0.0473) was higher in the sugammadex group than in the neostigmine group after surgery. The sugammadex group showed significantly lower incidence of postoperative severe hypoxemia (0.6% vs 6.3%, <jats:italic>p<\/jats:italic> = 0.006), shorter PACU stay (70 [60-90] min vs 90 [60-105] min, <jats:italic>p<\/jats:italic> &lt; 0.001), and reduced ICU admissions (0.6% vs 8.0%, <jats:italic>p<\/jats:italic> = 0.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Compared to cisatracurium-neostigmine, the rocuronium-sugammadex strategy for reversal of NMB showed a better recovery profile in patients undergoing kidney transplantation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13741-021-00231-2","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:04:04Z","timestamp":1642032244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Impact on grafted kidney function of rocuronium-sugammadex vs cisatracurium-neostigmine strategy for neuromuscular block management. An Italian single-center, 2014-2017 retrospective cohort case-control study"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5104-4124","authenticated-orcid":false,"given":"M.","family":"Carron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Andreatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Pesenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"De Cassai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Feltracco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Linassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sergi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Di Bella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Di Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Neri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Silvestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Furian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Navalesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,13]]},"reference":[{"issue":"3","key":"231_CR1","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/anae.14914","volume":"75","author":"DR Adams","year":"2020","unstructured":"Adams DR, Tollinche LE, Yeoh CB, Artman J, Mehta M, Phillips D, et al. Short-term safety and effectiveness of sugammadex for surgical patients with end-stage renal disease: a two-centre retrospective study. Anaesthesia. 2020;75(3):348\u201352. https:\/\/doi.org\/10.1111\/anae.14914.","journal-title":"Anaesthesia"},{"issue":"7","key":"231_CR2","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1016\/j.transproceed.2019.03.051","volume":"51","author":"R Arslantas","year":"2019","unstructured":"Arslantas R, Cevik BE. Retrospective investigation of grafted kidney function after reversal of neuromuscular blockade using neostigmine or sugammadex. Transplant Proc. 2019;51(7):2265\u20137. https:\/\/doi.org\/10.1016\/j.transproceed.2019.03.051.","journal-title":"Transplant Proc"},{"issue":"1","key":"231_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bja.2019.08.023","volume":"124","author":"M Blobner","year":"2020","unstructured":"Blobner M, Hunter JM, Meistelman C, Hoeft A, Hollmann MW, Kirmeier E, et al. Use of a train-of-four ratio of 0.95 versus 0.9 for tracheal extubation: an exploratory analysis of POPULAR data. Br J Anaesth. 2020;124(1):63\u201372. https:\/\/doi.org\/10.1016\/j.bja.2019.08.023.","journal-title":"Br J Anaesth"},{"issue":"1","key":"231_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jcrc.2008.10.010","volume":"24","author":"A Bom","year":"2009","unstructured":"Bom A, Hope F, Rutherford S, Thomson K. Preclinical pharmacology of sugammadex. J Crit Care. 2009;24(1):29\u201335. https:\/\/doi.org\/10.1016\/j.jcrc.2008.10.010.","journal-title":"J Crit Care"},{"issue":"10","key":"231_CR5","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3109\/0886022X.2011.618972","volume":"33","author":"H Bostan","year":"2011","unstructured":"Bostan H, Kalkan Y, Tomak Y, Tumkaya L, Altuner D, Y\u0131lmaz A, et al. Reversal of rocuronium-induced neuromuscular block with sugammadex and resulting histopathological effects in rat kidneys. Ren Fail. 2011;33(10):1019\u201324. https:\/\/doi.org\/10.3109\/0886022X.2011.618972.","journal-title":"Ren Fail"},{"issue":"1","key":"231_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/ALN.0000000000001409","volume":"126","author":"SJ Brull","year":"2017","unstructured":"Brull SJ, Kopman AF. Current status of neuromuscular reversal and monitoring: challenges and opportunities. Anesthesiology. 2017;126(1):173\u201390. https:\/\/doi.org\/10.1097\/ALN.0000000000001409.","journal-title":"Anesthesiology"},{"issue":"13","key":"231_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.14715\/cmb\/2018.64.13.14","volume":"64","author":"E B\u00fcy\u00fckf\u0131rat","year":"2018","unstructured":"B\u00fcy\u00fckf\u0131rat E, Koyuncu \u0130, Karahan MA, Binici O, Altay N, Kirmit A, et al. Comparison of the cytotoxic, genotoxic and apoptotic effects of sugammadex and neostigmine on human embryonic renal cell (HEK-293). Cell Mol Biol (Noisy-le-grand). 2018;64(13):74\u20138. https:\/\/doi.org\/10.14715\/cmb\/2018.64.13.14.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"3","key":"231_CR8","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/bja\/aes207","volume":"109","author":"G Cammu","year":"2012","unstructured":"Cammu G, Van Vlem B, van den Heuvel M, Stet L, el Galta R, Eloot S, et al. Dialysability of sugammadex and its complex with rocuronium in intensive care patients with severe renal impairment. Br J Anaesth. 2012;109(3):382\u201390. https:\/\/doi.org\/10.1093\/bja\/aes207.","journal-title":"Br J Anaesth"},{"key":"231_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/CEOR.S100921","volume":"8","author":"M Carron","year":"2016","unstructured":"Carron M, Baratto F, Zarantonello F, Ori C. Sugammadex for reversal of neuromuscular blockade: a retrospective analysis of clinical outcomes and cost-effectiveness in a single center. Clinicoecon Outcomes Res. 2016;8:43\u20135. https:\/\/doi.org\/10.2147\/CEOR.S100921.","journal-title":"Clinicoecon Outcomes Res"},{"key":"231_CR10","doi-asserted-by":"publisher","first-page":"109895","DOI":"10.1016\/j.jclinane.2020.109895","volume":"65","author":"M Carron","year":"2020","unstructured":"Carron M, Linassi F, De Cassai A. Role of sugammadex in accelerating postoperative discharge: an updated meta-analysis. J Clin Anesth. 2020;65:109895. https:\/\/doi.org\/10.1016\/j.jclinane.2020.109895.","journal-title":"J Clin Anesth"},{"key":"231_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jclinane.2016.06.018","volume":"35","author":"M Carron","year":"2016","unstructured":"Carron M, Zarantonello F, Tellaroli P, Ori C. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials. J Clin Anesth. 2016;35:1\u201312. https:\/\/doi.org\/10.1016\/j.jclinane.2016.06.018.","journal-title":"J Clin Anesth"},{"issue":"4","key":"231_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/MCC.0000000000000120","volume":"20","author":"A De Gasperi","year":"2014","unstructured":"De Gasperi A, Feltracco P, Ceravola E, Mazza E. Pulmonary complications in patients receiving a solid-organ transplant. Curr Opin Crit Care. 2014;20(4):411\u20139. https:\/\/doi.org\/10.1097\/MCC.0000000000000120.","journal-title":"Curr Opin Crit Care"},{"issue":"10","key":"231_CR13","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1097\/EJA.0000000000000312","volume":"32","author":"CM de Souza","year":"2015","unstructured":"de Souza CM, Tardelli MA, Tedesco H, Garcia NN, Caparros MP, Alvarez-Gomez JA, et al. Efficacy and safety of sugammadex in the reversal of deep neuromuscular blockade induced by rocuronium in patients with end-stage renal disease: a comparative prospective clinical trial. Eur J Anaesthesiol. 2015;32(10):681\u20136. https:\/\/doi.org\/10.1097\/EJA.0000000000000312.","journal-title":"Eur J Anaesthesiol"},{"key":"231_CR14","first-page":"605","volume":"69","author":"G Della Rocca","year":"2003","unstructured":"Della Rocca G, Pompei L, Coccia C, Costa MG, Cecchini V, Vilardi V, et al. Atracurium, cisatracurium, vecuronium and rocuronium in patients with renal failure. Minerva Anestesiol. 2003;69:605\u201311.","journal-title":"Minerva Anestesiol"},{"issue":"1","key":"231_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1164\/rccm.200512-1862OC","volume":"175","author":"M Eikermann","year":"2007","unstructured":"Eikermann M, Vogt FM, Herbstreit F, Vahid-Dastgerdi M, Zenge MO, Ochterbeck C, et al. The predisposition to inspiratory upper airway collapse during partial neuromuscular blockade. Am J Respir Crit Care Med. 2007;175(1):9\u201315. https:\/\/doi.org\/10.1164\/rccm.200512-1862OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"231_CR16","unstructured":"EMA. Bridion (sugammadex sodium) 100 mg\/mL: summary of product characteristics. In: . Available from URL: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000885\/WC500052310.pdf (Accessed January 25, 2021)."},{"issue":"5","key":"231_CR17","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1093\/bja\/aen037","volume":"100","author":"EA Flockton","year":"2008","unstructured":"Flockton EA, Mastronardi P, Hunter JM, Gomar C, Mirakhur RK, Aguilera L, et al. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine. Br J Anaesth. 2008;100(5):622\u201330. https:\/\/doi.org\/10.1093\/bja\/aen037.","journal-title":"Br J Anaesth"},{"issue":"10","key":"231_CR18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3390\/jcm7100307","volume":"7","author":"J Gameiro","year":"2018","unstructured":"Gameiro J, Agapito Fonseca J, Jorge S, Lopes JA. Acute kidney injury definition and diagnosis: a narrative review. J Clin Med. 2018;7(10):307. https:\/\/doi.org\/10.3390\/jcm7100307.","journal-title":"J Clin Med"},{"key":"231_CR19","doi-asserted-by":"publisher","first-page":"803","DOI":"10.12659\/MSM.897608","volume":"22","author":"Y Isik","year":"2016","unstructured":"Isik Y, Palabiyik O, Cegin BM, Goktas U, Kati I. Effects of sugammadex and neostigmine on renal biomarkers. Med Sci Monit. 2016;22:803\u20139. https:\/\/doi.org\/10.12659\/MSM.897608.","journal-title":"Med Sci Monit"},{"issue":"1 Suppl","key":"231_CR20","first-page":"S4","volume":"21","author":"CA Kellar","year":"2015","unstructured":"Kellar CA. Solid organ transplantation overview and delection criteria. Am J Manag Care. 2015;21(1 Suppl):S4\u201311.","journal-title":"Am J Manag Care"},{"issue":"6","key":"231_CR21","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1097\/ALN.0000000000003256","volume":"132","author":"S Kheterpal","year":"2020","unstructured":"Kheterpal S, Vaughn MT, Dubovoy TZ, Shah NJ, Bash LD, Colquhoun DA, et al. Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (STRONGER): a multicenter matched cohort analysis. Anesthesiology. 2020;132(6):1371\u201381. https:\/\/doi.org\/10.1097\/ALN.0000000000003256.","journal-title":"Anesthesiology"},{"issue":"12","key":"231_CR22","doi-asserted-by":"publisher","first-page":"746","DOI":"10.4149\/bll_2015_146","volume":"116","author":"G Kip","year":"2015","unstructured":"Kip G, Turgut HC, Alkan M, Aydin ME, Erbatur ME, Kiraz HA, et al. The effects of low and high doses of sugammadex on kidney tissue in streptozotocin-induced diabetic rats. Bratisl Lek Listy. 2015;116(12):746\u201350. https:\/\/doi.org\/10.4149\/bll_2015_146.","journal-title":"Bratisl Lek Listy"},{"issue":"2","key":"231_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S2213-2600(18)30294-7","volume":"7","author":"E Kirmeier","year":"2019","unstructured":"Kirmeier E, Eriksson LI, Lewald H, Jonsson Fagerlund M, Hoeft A, Hollmann M, et al. POPULAR Contributors. Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study. Lancet Respir Med. 2019;7(2):129\u201340. https:\/\/doi.org\/10.1016\/S2213-2600(18)30294-7.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"231_CR24","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1097\/ALN.0000000000000891","volume":"123","author":"F Kork","year":"2015","unstructured":"Kork F, Balzer F, Spies CD, Wernecke KD, Ginde AA, Jankowski J, et al. Minor postoperative increases of creatinine are associated with higher mortality and longer hospital length of stay in surgical patients. Anesthesiology. 2015;123(6):1301\u201311. https:\/\/doi.org\/10.1097\/ALN.0000000000000891.","journal-title":"Anesthesiology"},{"issue":"4","key":"231_CR25","doi-asserted-by":"publisher","first-page":"e37666","DOI":"10.5812\/numonthly.37666","volume":"8","author":"E Maraghi","year":"2016","unstructured":"Maraghi E, Rahimi Foroushani A, Younespour S, Rostami Z, Einollahi B, Eshraghian MR, et al. Longitudinal assessment of serum creatinine levels on graft survival after renal transplantation: joint modeling approach. Nephrourol Mon. 2016;8(4):e37666. https:\/\/doi.org\/10.5812\/numonthly.37666.","journal-title":"Nephrourol Mon"},{"issue":"01","key":"231_CR26","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4172\/2155-6148.1000270","volume":"4","author":"BS Martinez","year":"2013","unstructured":"Martinez BS, Gasanova I, Adesanya AO. Anesthesia for kidney transplantation-a review. J Anesth Clin Res. 2013;4(01):270. https:\/\/doi.org\/10.4172\/2155-6148.1000270.","journal-title":"J Anesth Clin Res"},{"issue":"3","key":"231_CR27","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/bja\/aex002","volume":"118","author":"A Miskovic","year":"2017","unstructured":"Miskovic A, Lumb AB. Postoperative pulmonary complications. Br J Anaesth. 2017;118(3):317\u201334. https:\/\/doi.org\/10.1093\/bja\/aex002.","journal-title":"Br J Anaesth"},{"issue":"3","key":"231_CR28","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.anclin.2017.04.005","volume":"35","author":"AM Mittel","year":"2017","unstructured":"Mittel AM, Wagener G. Anesthesia for kidney and pancreas transplantation. Anesthesiol Clin. 2017;35(3):439\u201352. https:\/\/doi.org\/10.1016\/j.anclin.2017.04.005.","journal-title":"Anesthesiol Clin"},{"key":"231_CR29","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.yrtph.2004.05.008","volume":"39","author":"IC Munro","year":"2004","unstructured":"Munro IC, Newberne PM, Young VR, B\u00e4r A. Safety assessment of gamma-cyclodextrin. Regul Toxicol Pharmacol. 2004;39:S3\u201313. https:\/\/doi.org\/10.1016\/j.yrtph.2004.05.008.","journal-title":"Regul Toxicol Pharmacol"},{"issue":"1","key":"231_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40981-018-0192-z","volume":"4","author":"Y Ono","year":"2018","unstructured":"Ono Y, Fujita Y, Kajiura T, Okawa H, Nakashima J, Isobe H, et al. Efficacy and safety of sugammadex in patients undergoing renal transplantation. JA Clin Rep. 2018;4(1):56. https:\/\/doi.org\/10.1186\/s40981-018-0192-z.","journal-title":"JA Clin Rep"},{"issue":"6","key":"231_CR31","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.kjms.2016.05.002","volume":"32","author":"S Ozbilgin","year":"2016","unstructured":"Ozbilgin S, Y\u0131lmaz O, Ergur BU, Hanc\u0131 V, Ozbal S, Yurtlu S, et al. Effectiveness of sugammadex for cerebral ischemia\/reperfusion injury. Kaohsiung J Med Sci. 2016;32(6):292\u2013301. https:\/\/doi.org\/10.1016\/j.kjms.2016.05.002.","journal-title":"Kaohsiung J Med Sci"},{"issue":"5","key":"231_CR32","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/bja\/aet586","volume":"114","author":"IF Panhuizen","year":"2015","unstructured":"Panhuizen IF, Gold SJ, Buerkle C, Snoeck MM, Harper NJ, Kaspers MJ, et al. Efficacy, safety and pharmacokinetics of sugammadex 4 mg kg-1 for reversal of deep neuromuscular blockade in patients with severe renal impairment. Br J Anaesth. 2015;114(5):777\u201384. https:\/\/doi.org\/10.1093\/bja\/aet586.","journal-title":"Br J Anaesth"},{"issue":"12","key":"231_CR33","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1007\/s12630-020-01812-3","volume":"67","author":"S Paredes","year":"2020","unstructured":"Paredes S, Porter SB, Porter IE 2nd, Renew JR. Sugammadex use in patients with end-stage renal disease: a historical cohort study. Can J Anaesth. 2020;67(12):1789\u201397. https:\/\/doi.org\/10.1007\/s12630-020-01812-3.","journal-title":"Can J Anaesth"},{"issue":"3","key":"231_CR34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/bdd.747","volume":"32","author":"P Peeters","year":"2011","unstructured":"Peeters P, Passier P, Smeets J, Zwiers A, de Zwart M, van de Wetering-Krebbers S, et al. Sugammadex is cleared rapidly and primarily unchanged via renal excretion. Biopharm Drug Dispos. 2011;32(3):159\u201367. https:\/\/doi.org\/10.1002\/bdd.747.","journal-title":"Biopharm Drug Dispos"},{"issue":"4","key":"231_CR35","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1097\/00000542-200604000-00009","volume":"104","author":"IF Sorgenfrei","year":"2006","unstructured":"Sorgenfrei IF, Norrild K, Larsen PB, Stensballe J, Ostergaard D, Prins ME, et al. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study. Anesthesiology. 2006;104(4):667\u201374. https:\/\/doi.org\/10.1097\/00000542-200604000-00009.","journal-title":"Anesthesiology"},{"issue":"2","key":"231_CR36","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00540-010-1090-3","volume":"25","author":"LM Staals","year":"2011","unstructured":"Staals LM, de Boer HD, van Egmond J, Hope F, van de Pol F, Bom AH, et al. Reversal of rocuronium-induced neuromuscular block by sugammadex is independent of renal perfusion in anesthetized cats. J Anesth. 2011;25(2):241\u20136. https:\/\/doi.org\/10.1007\/s00540-010-1090-3.","journal-title":"J Anesth"},{"issue":"4","key":"231_CR37","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/bja\/aen216","volume":"101","author":"LM Staals","year":"2008","unstructured":"Staals LM, Snoeck MM, Driessen JJ, Flockton EA, Heeringa M, Hunter JM. Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function. Br J Anaesth. 2008;101(4):492\u20137. https:\/\/doi.org\/10.1093\/bja\/aen216.","journal-title":"Br J Anaesth"},{"issue":"1","key":"231_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/bja\/aep340","volume":"104","author":"LM Staals","year":"2010","unstructured":"Staals LM, Snoeck MM, Driessen JJ, van Hamersvelt HW, Flockton EA, van den Heuvel MW, et al. Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study. Br J Anaesth. 2010;104(1):31\u20139. https:\/\/doi.org\/10.1093\/bja\/aep340.","journal-title":"Br J Anaesth"},{"issue":"9","key":"231_CR39","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1097\/EJA.0000000000000435","volume":"33","author":"C Unterbuchner","year":"2016","unstructured":"Unterbuchner C. Use of rocuronium and sugammadex in renal transplantation: problems that must be considered. Eur J Anaesthesiol. 2016;33(9):690\u20131. https:\/\/doi.org\/10.1097\/EJA.0000000000000435.","journal-title":"Eur J Anaesthesiol"},{"issue":"20","key":"231_CR40","first-page":"30545","volume":"S0041-1345","author":"M Vargas","year":"2020","unstructured":"Vargas M, Buonanno P, Sica A, Sabatella E, D\u2019Alessio FP, Alfieri S, et al. Effects of sugammadex plus rocuronium vs neostigmine plus cisatracurium during renal transplantation on graft function: a retrospective, case-control study. Transplant Proc. 2020;S0041-1345(20):30545.","journal-title":"Transplant Proc"},{"issue":"8","key":"231_CR41","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1097\/TP.0000000000003581","volume":"105","author":"G Wagener","year":"2020","unstructured":"Wagener G, Bezinover D, Wang C, Kroepfl E, Diaz G, Giordano C, et al. Fluid management during kidney transplantation: a consensus statement of the committee on transplant anesthesia of the American Society of Anesthesiologists. Transplantation. 2020;105(8):1677\u201384. https:\/\/doi.org\/10.1097\/TP.0000000000003581.","journal-title":"Transplantation."},{"issue":"5","key":"231_CR42","doi-asserted-by":"publisher","first-page":"e39292","DOI":"10.5812\/numonthly.39292","volume":"8","author":"S Younespour","year":"2016","unstructured":"Younespour S, Rahimi Foroushani A, Maraghi E, Rostami Z, Einollahi B, Eshraghian MR, et al. Longitudinal serum creatinine levels in relation to graft loss following renal transplantation: robust joint modeling of longitudinal measurements and survival time data. Nephrourol Mon. 2016;8(5):e39292. https:\/\/doi.org\/10.5812\/numonthly.39292.","journal-title":"Nephrourol Mon"}],"container-title":["Perioperative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13741-021-00231-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13741-021-00231-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13741-021-00231-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:04:36Z","timestamp":1642032276000},"score":1,"resource":{"primary":{"URL":"https:\/\/perioperativemedicinejournal.biomedcentral.com\/articles\/10.1186\/s13741-021-00231-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,13]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["231"],"URL":"https:\/\/doi.org\/10.1186\/s13741-021-00231-2","relation":{},"ISSN":["2047-0525"],"issn-type":[{"value":"2047-0525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,13]]},"assertion":[{"value":"22 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective observational study was approved by Institutional Review Board (Ethics Committee in Clinical Research-CESC of Padova, Italy, prot.n.42587, 16 July 2020), which waived the requirement to obtain patients\u2019 written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CM has received payments for lectures from Merck Sharp & Dohme (MSD), Italy. Other authors have no interests to disclose regarding this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}